ctDNA guiding adjuvant immunotherapy in urothelial carcinomaThomas Powles, Sanjeev Mariathasan, Petros Grivas et al.|Nature|2021Cited by 603
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trialThomas Powles, Christopher J. Sweeney, Kobe Yuen et al.|Nature Medicine|2022Cited by 241
IL-27 elicits a cytotoxic CD8+ T cell program to enforce tumour controlBéatrice Bréart, Nathaniel R. West, Katherine Williams et al.|Nature|2025Cited by 45